Combined, our team has over 40 years’ experience in the Australian STEM sector.
Dr Nadine Brew – Cincera Therapeutics
Dr Nadine Brew (B.A/B.Sc(Hons), PhD, GAICD) is General Manager at Cincera Therapeutics, a Brandon Capital-backed biotechnology company developing novel therapies to treat fibrotic conditions associated with metabolic diseases.
Dr Brew has broad experience in the translation and commercialisation of medical research including roles in not for profit, hopital and university sectors. She has led a range of commercial deals as well as industry engagement and partnering programs to progress research towards clinical trials. Nadine has over a decade’s research experience in Australia and the US with a PhD in developmental physiology from Monash University. She is a NHMRC postgraduate scholar and Churchill Fellow. Nadine is a graduate of the Australian Institute of Company Directors and has been an observer on numerous boards.
Dr Lauren Giorgio – GPN Vaccines
Lauren is the Chief Operating Officer of GPN Vaccines, a biotechnology company developing a serotype-independent pneumococcal vaccine. She has spent her career working alongside world-leading academics and clinicians to commercialise research across the pharmaceutical, medical device, digital health, and diagnostic sectors. Previously, she led the Business Development Office at the Centre for Eye Research Australia and prior to this, was part of the Business Development team at the Walter and Eliza Hall Institute. She has also been involved in the establishment, management and strategic direction of several small companies including OccuRx, Enlighten Imaging and Catalyst Therapeutics. Lauren is a mentor at IMNIS (Industry Mentoring Network in STEM) and was recently voted a Top 40 under 40 business leader in South Australia. Lauren holds a Bachelor of Health Science (Hons) and PhD from the University of Adelaide and is a Graduate of the Australian Institute of Company Directors.
Dr Udani Reets – Peter MacCallum Cancer Centre
Dr Udani Reets (B.Sc(Hons), PhD) is Director Partnerships at the Peter MacCallum Cancer Centre, one of the world’s leading cancer research centres. Dr Reets has significant expertise in creating large-scale partnerships to support the translation of research into improvements in health policy and practice. She is driven by an ambition to make a contribution to improving health and wellbeing globally.
Prior to this role, Udani led the development of major projects and initiatives as the Strategic Development Manager at the Faculty of Medicine, Nursing and Health Science, Monash University. Previously, as a medical researcher, she was awarded a Victorian Fellowship for her contribution to the field of behavioural neuroscience.
Udani holds a Bachelor of Science (Hons) and PhD from Monash University.
COMMUNICATIONS & MARKETING
Annabelle Dick – Brandon Capital Partners
Annabelle (Ngāpuhi – Ngāti Wharara, Te Popoto) is Communications & Engagement Officer at Brandon Capital Partners. Prior to this, Annabelle worked with Crown entities, the New Zealand Infrastructure Commission and the New Zealand Institute of Skills & Training (NZIST) Establishment Unit, advising on media relations, stakeholder engagement and public consultation.
As a public relations specialist, she has worked across health, biotech, higher education, enterprise and not-for-profit sectors. She started her career as a journalist in New Zealand. Her career highlights include showing a short film at the Cannes Film Festival and working with international top tier media to promote Alzheimer’s disease as a global health priority.
Annabelle has a Bachelor in Broadcast Communications (Journalism) from the New Zealand Broadcasting School and a Certificate in Iwi Engagement from the Public Relations Institute of New Zealand (PRINZ).
THE WILD ADVISORY COMMITTEE
The WILD Advisory Committee comprises a mix of external representatives to engage with leaders in the STEM sector. This group offers the perspective of key stakeholder groups and provides advice and guidance to the Project Team.
The members of the Advisory committee will be announced shortly.